Wellington Management Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $150M | Buy |
|
|||||
|
2023
Q1 | $129M | Sell |
|
|||||
|
2022
Q4 | $57.3M | Sell |
|
|||||
|
2022
Q3 | $39.5M | Sell |
|
|||||
|
2022
Q2 | $122M | Sell |
|
|||||
|
2022
Q1 | $144M | Buy |
|
|||||
|
2021
Q4 | $112M | Buy |
|
|||||
|
2021
Q3 | $427M | Sell |
|
|||||
|
2021
Q2 | $612M | Sell |
|
|||||
|
2021
Q1 | $434M | Buy |
|
|||||
|
2020
Q4 | $537M | Buy |
|
|||||
|
2020
Q3 | $389M | Buy |
|
|||||
|
2020
Q2 | $584M | Buy |
|
|||||
|
2020
Q1 | $436M | Buy |
|
|||||
|
2019
Q4 | $489M | Buy |
|
|||||
|
2019
Q3 | $41.3M | Buy |
|
|||||
|
2019
Q2 | $47.6M | Buy |
|